European Journal of Case Reports in Internal Medicine (Mar 2021)

Delayed Recognition of Levetiracetam-induced Pancytopenia

  • Mohammad Ammad Ud Din,
  • Syed Ather Hussain,
  • Amy Bodrog

DOI
https://doi.org/10.12890/2021_002449

Abstract

Read online

Blood dyscrasias associated with levetiracetam use can be difficult to identify, especially when other potential differential diagnoses are concurrently present. Here we present a 57-year-old man with metastatic adenocarcinoma of unknown primary origin on levetiracetam who initially presented with an in-stent thrombosis of the right external iliac vein and then developed worsening thrombocytopenia followed by pancytopenia. Levetiracetam was not identified as the culprit until other causes like platelet consumption, heparin-induced thrombocytopenia, idiopathic immune thrombocytopenic purpura, and bone marrow involvement by metastatic disease were ruled out.

Keywords